Stifel resumed coverage of Orthofix (OFIX) with a Buy rating and $22 price target The firm believes “profitable growth at an attractive valuation” makes it easier to own the shares as investors await long-term ET tailwinds benefiting 7D FLASH, the analyst says while resuming coverage of the spine industry.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OFIX: